REG - CVS Group plc - Result of AGM

CVSAnnouncement

23/11/2022 14:45

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221123:nRSW3952Ha&default-theme=true

RNS Number : 3952H  CVS Group plc  23 November 2022

23 November 2022

 

CVS Group plc

("CVS" or the "Company")

 

Result of AGM

 

CVS, one of the UK's leading providers of integrated veterinary services,
announces that at the Company's Annual General Meeting ("AGM") held earlier
today, all of the resolutions proposed, as set out in the Notice of AGM, were
passed on a poll.  Resolutions 1 to 14 were passed as ordinary resolutions
and resolutions 15 to 18 were passed as special resolutions.

 

A summary of proxy votes received for each resolution will shortly be
available alongside the Notice of AGM on the Company's website,
https://www.cvsukltd.co.uk/investor-centre
(https://www.cvsukltd.co.uk/investor-centre) /agm

 Contacts:

CVS Group plc
 
                via Camarco

Richard Fairman, CEO

Jenny Farrer, Group Company Secretary

 

Peel Hunt LLP (Nominated Adviser & Broker)
                                +44 (0)20 7418 8900

Adrian Trimmings / Michael Burke / Andrew Clark / Lalit Bose

 

Berenberg (Joint
Broker)
+44 (0)20 3207 7800

Toby Flaux / Ben Wright / Ciaran Walsh / Milo Bonser

 

Camarco (Financial
PR)

Geoffrey Pelham-Lane
                                             +44
(0)7733 124 226

Ginny Pulbrook
 
 +44 (0)7961 315 138

   Toby Strong                                                                                                      +44 (0)7789 151 644

 

About CVS Group plc (www.cvsukltd.co.uk (http://www.cvsukltd.co.uk/) )

CVS Group is an AIM-quoted fully-integrated provider of veterinary services in
the UK, with practices in the Netherlands and the Republic of Ireland. CVS is
focused on providing high quality clinical services to its customers and their
animals, with outstanding and dedicated clinical teams and support colleagues
at the core of its strategy.

The Group has c.500 veterinary practices across its three markets, including
eight specialist referral hospitals and 37 dedicated out-of-hours sites.
Alongside the core Veterinary Practices division, CVS operates Laboratories
(providing diagnostic services to CVS and third-parties), Crematoria
(providing pet cremation and clinical waste disposal for CVS and third-party
practices), Buying Groups and the Group's online retail business ("Animed
Direct").

The Group employs c.8,100 personnel, including c.2,100 veterinary surgeons
and c.3,000 nurses.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RAGBSBDBGXDDGDX